Patents by Inventor Robert N. Booher

Robert N. Booher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
    Publication number: 20030186881
    Abstract: Compositions of matter consisting of a family of related nucleic acid sequences that encode proteins, termed Cell Growth Regulatory Proteins, that phosphorylate cell cycle targets, and methods of using the nucleotide sequences and the proteins encoded thereby, to diagnose and/or treat disease where the Cell Growth Regulatory Proteins have an apparent molecular weight of about 54.6 kdaltons.
    Type: Application
    Filed: May 6, 2003
    Publication date: October 2, 2003
    Inventors: Robert N. Booher, Ali Fattaey
  • Method and reagent for the inhibition of checkpoint kinase-1 (Chk1) enzyme
    Publication number: 20030087847
    Abstract: The present invention relates to nucleic acid molecules, including antisense and enzymatic nucleic acid molecules, such as hammerhead ribozymes, DNAzymes, and antisense, which modulate the expression of the Chk-1 gene.
    Type: Application
    Filed: February 2, 2001
    Publication date: May 8, 2003
    Applicant: Onyx Pharmaceuticals, Inc.
    Inventors: Thale Jarvis, James McSwiggen, Robert N. Booher, Patricia S. Holman, Ali R. Fattaey
  • Nucleic acid that encode a cell growth regulatory protein
    Patent number: 6558918
    Abstract: Compositions of matter consisting of a family of related nucleic acid sequences that encode proteins, termed Cell Growth Regulatory Proteins, that phosphorylate cell cycle targets, and methods of using the nucleotide sequences and the proteins encoded thereby, to diagnose and/or treat disease where the Cell Growth Regulatory Proteins have an apparent molecular weight of about 54.6 kdaltons.
    Type: Grant
    Filed: October 15, 1997
    Date of Patent: May 6, 2003
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventors: Robert N. Booher, Ali Fattaey